2012 -2017 Senior Director Neuroscience Discovery, Europe @
2010 -now Independent Consultant @ JAK consulting
2011 -2012 Chairman @ NeuroSolutions Ltd
2005 -now Chief Research and Development Officer @ Evotec AG
2002 -2005 CEO @ Evotec Neurosciences
1999 -now Head of CNS Research @
1994 -now Research Area Head for Neurodegenerative Diseases @
1983 -now Section Leader @ Merck, Sharp and Dohme
John Kemp Education
University of Southampton
Ph.D (Neuroscience/Neuropharmacology)
1974-1977
University of Portsmouth
B.Sc. (Pharmacology)
1971-1974
John Kemp Skills
Drug Discovery
Drug Development
Clinical Development
Pharmacology
Neuroscience
Electrophysiology
R&D
In Vitro
Clinical Research
Infectious Diseases
Biotechnology
Biopharmaceuticals
Toxicology
Cell Culture
Lifesciences
Oncology
Pharmaceutical Industry
Medicinal Chemistry
Technology Transfer
Neurodegeneration
CRO
Strategy
Biochemistry
Translational Medicine
Biomarkers
Biomarker Discovery
Clinical Trials
GCP
In Vivo
Assay Development
Cell Biology
Cell
Immunology
Life Sciences
John Kemp Summary
John Kemp, based in Basel, BS, CH, is currently a Owner at JAK & Gill Consulting GmbH. John Kemp brings experience from previous roles at Hoba Therapeutics, AbbVie, Syndesi Therapeutics and The Janssen Pharmaceutical Companies of Johnson & Johnson. John Kemp holds a 1974 - 1977 Ph.D in Neuroscience/Neuropharmacology @ University of Southampton. With a robust skill set that includes Drug Discovery, Drug Development, Clinical Development, Pharmacology, Neuroscience and more. John Kemp has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.